Skip to main content
SpringerLink
Log in

Pathology of the Parathyroid Glands

  • Chapter
  • First Online:
Atlas of Parathyroid Imaging and Pathology

  • 497 Accesses

Abstract

The parathyroid glands act as primary regulator of calcium homeostasis through secretion of parathyroid hormone. Hyperparathyroidism can be due to autonomously functioning adenoma, hyperplasia, and rarely, carcinoma. Parathyroidectomy is highly effective in achieving durable biochemical cure. Distinguishing single-gland adenoma and multigland hyperplasia is aided by preoperative imaging localization studies. Intraoperative assessment includes frozen section analysis and parathyroid hormone monitoring. Frozen section analysis is accurate in confirming parathyroid tissue but less robust in evaluating its functional status. Recent research into the molecular basis of sporadic and familial hyperparathyroidism has provided insight into pathogenesis of uncontrolled hyperfunctionality of the parathyroid gland. This chapter outlines major categories and histopathology of parathyroid lesions underlying hyperparathyroidism, including parathyroid adenoma, atypical parathyroid adenoma, parathyroid hyperplasia, and parathyroid carcinoma. Syndromes of familial hyperparathyroidism are cataloged in the context of their molecular pathogenesis. Less common lesions covered include parathyroid cyst, parathyromatosis, and metastasis to the parathyroid gland.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gilmour JR, Martin WJ. The weight of the parathyroid glands. J Pathol Bacteriol. 1937;44:431–62.

    Google Scholar 

  2. Dekker A, Dunsford HA, Geyer SJ. The normal parathyroid gland at autopsy: the significance of stromal fat in adult patients. J Pathol. 1979;128:127–32.

    CAS  PubMed  Google Scholar 

  3. Akerström G, Malmaeus J, Bergström R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95:14–21.

    PubMed  Google Scholar 

  4. Gomes EM, Nunes RC, Lacativa PG, Almeida MH, Franco FM, Leal CT, et al. Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras. 2007;22:105–9.

    PubMed  Google Scholar 

  5. Grevellec A, Tucker AS. The pharyngeal pouches and clefts: development, evolution, structure and derivatives. Semin Cell Dev Biol. 2010;21:325–32.

    PubMed  Google Scholar 

  6. LoPinto M, Rubio GA, Khan ZF, Vaghaiwalla TM, Farra JC, Lew JI. Location of abnormal parathyroid glands: lessons from 810 parathyroidectomies. J Surg Res. 2017;207:22–6.

    PubMed  Google Scholar 

  7. Wang C. The anatomic basis of parathyroid surgery. Ann Surg. 1976;183:271–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Nanka O, Sedý J, Vítková I, Libánský P, Adámek S. Surgical anatomy of parathyroid glands with emphasis on parathyroidectomy. Prague Med Rep. 2006;107:261–72.

    CAS  PubMed  Google Scholar 

  9. Wong KS, Lewis JS Jr, Gottipati S, Chernock RD. Utility of birefringent crystal identification by polarized light microscopy in distinguishing thyroid from parathyroid tissue on intraoperative frozen sections. Am J Surg Pathol. 2014;38:1212–9.

    PubMed  Google Scholar 

  10. Dufour DR, Wilkerson SY. The normal parathyroid revisited: percentage of stromal fat. Hum Pathol. 1982;13:717–21.

    CAS  PubMed  Google Scholar 

  11. Obara T, Fujimoto Y, Aiba M. Stromal fat content of the parathyroid gland. Endocrinol Jpn. 1990;37:901–5.

    CAS  PubMed  Google Scholar 

  12. Iwasaki A, Shan L, Kawano I, Nakamura M, Utsuno H, Kobayashi A, et al. Quantitative analysis of stromal fat content of human parathyroid glands associated with thyroid diseases using computer image analysis. Pathol Int. 1995;45:483–6.

    CAS  PubMed  Google Scholar 

  13. Roth SI, Munger BL. The cytology of the adenomatous, atrophic, and hyperplastic parathyroid glands of man. A light- and electron-microscopic study. Virchows Arch Pathol Anat Physiol Klin Med. 1962;335:389–410.

    CAS  PubMed  Google Scholar 

  14. Thiele J, Kärner J, Fischer R. Ultrastructural morphometry on human parathyroid tissue. Morphological and functional implications. J Submicrosc Cytol Pathol. 1988;20:491–500.

    CAS  PubMed  Google Scholar 

  15. Roth SI, Gallagher MJ. The rapid identification of “normal” parathyroid glands by the presence of intracellular fat. Am J Pathol. 1976;84:521–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Saffos RO, Rhatigan RM. Intracellular lipid in parathyroid glands. Hum Pathol. 1979;10:483–5.

    CAS  PubMed  Google Scholar 

  17. King DT, Hirose FM. Chief cell intracytoplasmic fat used to evaluate parathyroid disease by frozen section. Arch Pathol Lab Med. 1979;103:609–12.

    CAS  PubMed  Google Scholar 

  18. Kasdon EJ, Rosen S, Cohen RB, Silen W. Surgical pathology of hyperparathyroidism. Usefulness of fat stain and problems in interpretation. Am J Surg Pathol. 1981;5:381–4.

    CAS  PubMed  Google Scholar 

  19. Dufour DR, Durkowski C. Sudan IV stain. Its limitations in evaluating parathyroid functional status. Arch Pathol Lab Med. 1982;106:224–7.

    CAS  PubMed  Google Scholar 

  20. Farnebo LO, von Unge H. Peroperative evaluation of parathyroid glands using fat stain on frozen sections. Advantages and limitations. Acta Chir Scand Suppl. 1984;520:17–24.

    CAS  PubMed  Google Scholar 

  21. DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;132:1251–62.

    PubMed  Google Scholar 

  22. Habib Z, Camacho P. Primary hyperparathyroidism: an update. Curr Opin Endocrinol Diabetes Obes. 2010;17:554–60.

    CAS  PubMed  Google Scholar 

  23. Mather HG. Hyperparathyroidism with normal serum calcium. Br Med J. 1953;2(4833):424–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. McSwiney RR, Prunty FT. The diagnosis of minimal hyperparathyroidism-determination of theoretical renal phosphorus threshold. Proc R Soc Med. 1961;54:639–40.

    CAS  PubMed  Google Scholar 

  25. Eastell R, Brandi ML, Costa AG, D’Amour P, Shoback DM, Thakker RV. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3570–9.

    CAS  PubMed  Google Scholar 

  26. Carlson D. Parathyroid pathology: hyperparathyroidism and parathyroid tumors. Arch Pathol Lab Med. 2010;134:1639–44.

    PubMed  Google Scholar 

  27. LiVolsi VA, Montone KT, Baloch ZN. Parathyroid: the pathology of hyperparathyroidism. Surg Pathol Clin. 2014;7:515–31.

    PubMed  Google Scholar 

  28. Richert L, Trombetti A, Herrmann FR, Triponez F, Meier C, Robert JH, Rizzoli R. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly. 2009;139:400–4.

    PubMed  Google Scholar 

  29. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17(Suppl 2):N18–23.

    PubMed  Google Scholar 

  30. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, Melton LJ 3rd. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21:171–7.

    PubMed  Google Scholar 

  31. Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98:1122–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Rao SD, Frame B, Miller MJ, Kleerekoper M, Block MA, Parfitt AM. Hyperparathyroidism following head and neck irradiation. Arch Intern Med. 1980;140:205–7.

    CAS  PubMed  Google Scholar 

  33. Bendz H, Sjödin I, Toss G, Berglund K. Hyperparathyroidism and long-term lithium therapy--a cross-sectional study and the effect of lithium withdrawal. J Intern Med. 1996;240:357–65.

    CAS  PubMed  Google Scholar 

  34. Carling T, Correa P, Hessman O, Hedberg J, Skogseid B, Lindberg D, et al. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab. 1998;83:2960–3.

    CAS  PubMed  Google Scholar 

  35. Farnebo F, Teh BT, Kytölä S, Svensson A, Phelan C, Sandelin K, et al. Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab. 1998;83:2627–30.

    CAS  PubMed  Google Scholar 

  36. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, et al. Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet. 1997;16:375–8.

    CAS  PubMed  Google Scholar 

  37. Uchino S, Noguchi S, Sato M, Yamashita H, Yamashita H, Watanabe S, et al. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res. 2000;60:5553–7.

    CAS  PubMed  Google Scholar 

  38. Newey PJ, Nesbit MA, Rimmer AJ, Attar M, Head RT, Christie PT, et al. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas. J Clin Endocrinol Metab. 2012;97:E1995–2005.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Cromer MK, Starker LF, Choi M, Udelsman R, Nelson-Williams C, Lifton RP, Carling T. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J Clin Endocrinol Metab. 2012;97:E1774–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K, Joensuu H. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol. 2001;158:1355–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Tominaga Y, Tsuzuki T, Uchida K, Haba T, Otsuka S, Ichimori T, et al. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. Kidney Int. 1999;55:1375–83.

    CAS  PubMed  Google Scholar 

  42. Yi Y, Nowak NJ, Pacchia AL, Morrison C. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays. Genes Chromosomes Cancer. 2008;47:639–48.

    CAS  PubMed  Google Scholar 

  43. Cardoso L, Stevenson M, Thakker RV. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma. Hum Mutat. 2017;38:1621–48.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Marx SJ. New concepts about familial isolated hyperparathyroidism. J Clin Endocrinol Metab. 2019;104:4058–66.

    PubMed Central  Google Scholar 

  45. Guan B, Welch JM, Sapp JC, Ling H, Li Y, Johnston JJ, et al. GCM2-activating mutations in familial isolated hyperparathyroidism. Am J Hum Genet. 2016;99:1034–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM, et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab. 2013;98:2734–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Rejnmark L, Amstrup AK, Mollerup CL, Heickendorff L, Mosekilde L. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study. J Clin Endocrinol Metab. 2013;98:87–96.

    CAS  PubMed  Google Scholar 

  48. Portillo MR, Rodríguez-Ortiz ME. Secondary hyperparathyroidism: pathogenesis, diagnosis, preventive and therapeutic strategies. Rev Endocr Metab Disord. 2017;18:79–95.

    CAS  PubMed  Google Scholar 

  49. Messa P, Alfieri CM. Secondary and tertiary hyperparathyroidism. Front Horm Res. 2019;51:91–108.

    CAS  PubMed  Google Scholar 

  50. VanderWalde LH, Liu IL, Haigh PI. Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World J Surg. 2009;33:406–11.

    PubMed  Google Scholar 

  51. Cipriani C, Biamonte F, Costa AG, Zhang C, Biondi P, Diacinti D, et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab. 2015;100:1309–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Zhang L, Liu X, Li H. Long-term skeletal outcomes of primary hyperparathyroidism patients after treatment with parathyroidectomy: a systematic review and meta-analysis. Horm Metab Res. 2018;50:242–9.

    CAS  PubMed  Google Scholar 

  53. Scholz DA, Purnell DC. Asymptomatic primary hyperparathyroidism. 10-year prospective study. Mayo Clin Proc. 1981;56:473–8.

    CAS  PubMed  Google Scholar 

  54. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249–55.

    CAS  PubMed  Google Scholar 

  55. Castleman B, Mallory TB. The pathology of the parathyroid gland in hyperparathyroidism: a study of 25 cases. Am J Pathol. 1935;11:1–72.17.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Phitayakorn R, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg. 2006;191:418–23.

    PubMed  Google Scholar 

  57. Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013;37:102–6.

    PubMed  Google Scholar 

  58. Albuja-Cruz MB, Allan BJ, Parikh PP, Lew JI. Efficacy of localization studies and intraoperative parathormone monitoring in the surgical management of hyperfunctioning ectopic parathyroid glands. Surgery. 2013;154:453–60.

    PubMed  Google Scholar 

  59. Thompson NW, Eckhauser FE, Harness JK. The anatomy of primary hyperparathyroidism. Surgery. 1982;92:814–21.

    CAS  PubMed  Google Scholar 

  60. Baloch ZW, LiVolsi VA. Double adenoma of the parathyroid gland: does the entity exist? Arch Pathol Lab Med. 2001;125:178–9.

    CAS  PubMed  Google Scholar 

  61. De Gregorio L, Lubitz CC, Hodin RA, Gaz RD, Parangi S, Phitayakorn R, Stephen AE. The truth about double adenomas: incidence, localization, and intraoperative parathyroid hormone. J Am Coll Surg. 2016;222:1044–52.

    PubMed  Google Scholar 

  62. Goasguen N, Chirica M, Roger N, Munoz-Bongrand N, Zohar S, Noullet S, et al. Primary hyperparathyroidism from parathyroid microadenoma: specific features and implications for a surgical strategy in the era of minimally invasive parathyroidectomy. J Am Coll Surg. 2010;210:456–62.

    PubMed  Google Scholar 

  63. Abbona GC, Papotti M, Gasparri G, Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol. 1995;26:135–8.

    CAS  PubMed  Google Scholar 

  64. Baloch ZW, LiVolsi VA. Pathology of the parathyroid glands in hyperparathyroidism. Semin Diagn Pathol. 2013;30:165–77.

    PubMed  Google Scholar 

  65. Erovic BM, Harris L, Jamali M, Goldstein DP, Irish JC, Asa SL, Mete O. Biomarkers of parathyroid carcinoma. Endocr Pathol. 2012;23:221–31.

    CAS  PubMed  Google Scholar 

  66. Boquist L. Follicles in human parathyroid glands. Lab Investig. 1973;28:313–20.

    CAS  PubMed  Google Scholar 

  67. Isotalo PA, Lloyd RV. Presence of birefringent crystals is useful in distinguishing thyroid from parathyroid gland tissues. Am J Surg Pathol. 2002;26:813–4.

    PubMed  Google Scholar 

  68. Bai S, LiVolsi VA, Fraker DL, Bing Z. Water-clear parathyroid adenoma: report of two cases and literature review. Endocr Pathol. 2012;23:196–200.

    PubMed  Google Scholar 

  69. Elgoweini M, Chetty R. Hyalinizing parathyroid adenoma and hyperplasia: report of 3 cases of an unusual histologic variant. Ann Diagn Pathol. 2011;15:329–32.

    PubMed  Google Scholar 

  70. van Hoeven KH, Brennan MF. Lipothymoadenoma of the parathyroid. Arch Pathol Lab Med. 1993;117:312–4.

    PubMed  Google Scholar 

  71. Rosai J, DeLellis RA, Carcangiu ML, Frable WJ, Tallin G. Parathyroid adenoma and variants. In: Tumors of the thyroid and parathyroid glands. Armed Forces Institute of Pathology, Atlas of tumor pathology 4th series. Silver Spring, MD: American Registry of Pathology; 2014. p. 513–42.

    Google Scholar 

  72. DeLellis R, Franssila KO, Arnold A, Haigh PI, Eng C, Hendy GN, et al. Parathyroid adenoma. In: Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO classification of tumours of endocrine organs, International Agency for Research on Cancer. 4th ed. Lyon, France; 2017. p. 153–8.

    Google Scholar 

  73. Schneider R, Bartsch-Herzog S, Ramaswamy A, Bartsch DK, Karakas E. Immunohistochemical expression of E-cadherin in atypical parathyroid adenoma. World J Surg. 2015;39:2477–83.

    PubMed  Google Scholar 

  74. Cetani F, Marcocci C, Torregrossa L, Pardi E. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Endocr Relat Cancer. 2019;26:R441–64.

    CAS  PubMed  Google Scholar 

  75. Fernandez-Ranvier GG, Khanafshar E, Jensen K, Zarnegar R, Lee J, Kebebew E, et al. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer. 2007;110:255–64.

    PubMed  Google Scholar 

  76. Kruijff S, Sidhu SB, Sywak MS, Gill AJ, Delbridge LW. Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol. 2014;21:426–33.

    PubMed  Google Scholar 

  77. Guarnieri V, Battista C, Muscarella LA, Bisceglia M, de Martino D, Baorda F, et al. CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Cell Oncol (Dordr). 2012;35:411–22.

    CAS  PubMed  Google Scholar 

  78. Agarwal A, Pradhan R, Kumari N, Krishnani N, Shukla P, Gupta SK, et al. Molecular characteristics of large parathyroid adenomas. World J Surg. 2016;40:607–14.

    PubMed  Google Scholar 

  79. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest. 1995;95:2047–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Tominaga Y, Kohara S, Namii Y, Nagasaka T, Haba T, Uchida K, et al. Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg. 1996;20:744–50; discussion 750–2

    CAS  PubMed  Google Scholar 

  81. Shan L, Nakamura Y, Murakami M, Nakamura M, Naito A, Kawahara K, et al. Clonal emergence in uremic parathyroid hyperplasia is not related to MEN1 gene abnormality. Jpn J Cancer Res. 1999;90:965–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Vandenbulcke O, Delaere P, Vander Poorten V, Debruyne F. Incidence of multiglandular disease in sporadic primary hyperparathyroidism. B-ENT. 2014;10:1–6.

    CAS  PubMed  Google Scholar 

  83. Berger AC, Libutti SK, Bartlett DL, Skarulis MG, Marx SJ, Spiegel AM, et al. Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia. J Am Coll Surg. 1999;188:382–9.

    CAS  PubMed  Google Scholar 

  84. Ezzat T, Maclean GM, Parameswaran R, Phillips B, Komar V, Mihai R, et al. Primary hyperparathyroidism with water clear cell content: the impact of histological diagnosis on clinical management and outcome. Ann R Coll Surg Engl. 2013;95:e60–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Boutzios G, Sarlanis H, Kolindou A, Velidaki A, Karatzas T. Primary hyperparathyroidism caused by enormous unilateral water-clear cell parathyroid hyperplasia. BMC Endocr Disord. 2017;17:57.

    PubMed  PubMed Central  Google Scholar 

  86. Straus FH 2nd, Kaplan EL, Nishiyama RH, Bigos ST. Five cases of parathyroid lipohyperplasia. Surgery. 1983;94:901–5.

    PubMed  Google Scholar 

  87. Carter JM, Landry A, Hinni M. Lipohyperplasia of the parathyroid glands. Ear Nose Throat J. 2012;91:441–3.

    PubMed  Google Scholar 

  88. Krause MW, Hedinger CE. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol. 1985;16:772–84.

    CAS  PubMed  Google Scholar 

  89. Nasrallah MP, Fraker DL, LiVolsi VA. Parathyroid carcinoma in the setting of tertiary hyperparathyroidism after renal transplant. Endocr Pathol. 2014;25:433–5.

    PubMed  Google Scholar 

  90. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–44.

    CAS  PubMed  Google Scholar 

  91. Wang CA, Gaz RD. Natural history of parathyroid carcinoma. Diagnosis, treatment, and results. Am J Surg. 1985;149:522–7.

    CAS  PubMed  Google Scholar 

  92. Harari A, Waring A, Fernandez-Ranvier G, Hwang J, Suh I, Mitmaker E, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96:3679–86.

    CAS  PubMed  Google Scholar 

  93. Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, et al. Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015;22:3990–5.

    PubMed  Google Scholar 

  94. Robert JH, Trombetti A, Garcia A, Pache JC, Herrmann F, Spiliopoulos A, Rizzoli R. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature. Ann Surg Oncol. 2005;12:526–32.

    PubMed  Google Scholar 

  95. Talat N, Schulte KM. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol. 2010;17:2156–74.

    PubMed  Google Scholar 

  96. Fernandez-Ranvier GG, Jensen K, Khanafshar E, Quivey JM, Glastonbury C, Kebebew E, et al. Nonfunctioning parathyroid carcinoma: case report and review of literature. Endocr Pract. 2007;13:750–7.

    PubMed  Google Scholar 

  97. Wilkins BJ, Lewis JS Jr. Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol. 2009;3:140–9.

    PubMed  PubMed Central  Google Scholar 

  98. Cetani F, Frustaci G, Torregrossa L, Magno S, Basolo F, Campomori A, et al. A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule. World J Surg Oncol. 2015;13:270.

    PubMed  PubMed Central  Google Scholar 

  99. Lee KM, Kim EJ, Choi WS, Park WS, Kim SW. Intrathyroidal parathyroid carcinoma mimicking a thyroid nodule in a MEN type 1 patient. J Clin Ultrasound. 2014;42:212–4.

    PubMed  Google Scholar 

  100. Vila Duckworth L, Winter WE, Vaysberg M, Moran CA, Al-Quran SZ. Intrathyroidal parathyroid carcinoma: report of an unusual case and review of the literature. Case Rep Pathol. 2013;2013:198643.

    PubMed  PubMed Central  Google Scholar 

  101. DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol. 2005;12:53–61.

    PubMed  Google Scholar 

  102. Wynne AG, van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore). 1992;71:197–205.

    CAS  Google Scholar 

  103. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.

    PubMed  Google Scholar 

  104. Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109:1736–41.

    PubMed  Google Scholar 

  105. Schantz A, Castleman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31:600–5.

    CAS  PubMed  Google Scholar 

  106. Tamler R, Lewis MS, LiVolsi VA, Genden EM. Parathyroid carcinoma: ultrasonographic and histologic features. Thyroid. 2005;15:744–5.

    PubMed  Google Scholar 

  107. Vasef MA, Brynes RK, Sturm M, Bromley C, Robinson RA. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol. 1999;12:412–6.

    CAS  PubMed  Google Scholar 

  108. Stojadinovic A, Hoos A, Nissan A, Dudas ME, Cordon-Cardo C, Shaha AR, et al. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003;34:54–64.

    PubMed  Google Scholar 

  109. Kim HK, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, et al. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma. Head Neck. 2012;34:201–6.

    PubMed  Google Scholar 

  110. Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH. Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer. 2009;115:334–44.

    PubMed  Google Scholar 

  111. Bergero N, De Pompa R, Sacerdote C, Gasparri G, Volante M, Bussolati G, Papotti M. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol. 2005;36:908–14.

    CAS  PubMed  Google Scholar 

  112. Juhlin CC, Nilsson IL, Lagerstedt-Robinson K, Stenman A, Bränström R, Tham E, Höög A. Parafibromin immunostainings of parathyroid tumors in clinical routine: a near-decade experience from a tertiary center. Mod Pathol. 2019;32:1082–94.

    CAS  PubMed  Google Scholar 

  113. Pyo JS, Cho WJ. Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinoma. Biosci Rep. 2019;39(4). pii: BSR20181778. https://doi.org/10.1042/BSR20181778.

  114. Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol. 1999;8:155–65.

    CAS  PubMed  Google Scholar 

  115. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724–31.

    CAS  PubMed  Google Scholar 

  116. Witteveen JE, Hamdy NA, Dekkers OM, Kievit J, van Wezel T, Teh BT, et al. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Mod Pathol. 2011;24:688–97.

    CAS  PubMed  Google Scholar 

  117. Cetani F, Banti C, Pardi E, Borsari S, Viacava P, Miccoli P, et al. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect. 2013;2:186–95.

    CAS  PubMed  PubMed Central  Google Scholar 

  118. Cetani F, Saponaro F, Borsari S, Marcocci C. Familial and hereditary forms of primary hyperparathyroidism. Front Horm Res. 2019;51:40–51.

    CAS  PubMed  Google Scholar 

  119. Kamilaris CDC, Stratakis CA. Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis. Front Endocrinol (Lausanne). 2019;10:339.

    Google Scholar 

  120. Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia Type 1 and 2. Presse Med. 2018;47:722–31.

    PubMed  Google Scholar 

  121. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404–7.

    CAS  PubMed  Google Scholar 

  122. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet. 1997;6:1177–83.

    CAS  PubMed  Google Scholar 

  123. Matkar S, Thiel A, Hua X. Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem Sci. 2013;38:394–402.

    CAS  PubMed  PubMed Central  Google Scholar 

  124. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A. 2005;102:749–54.

    CAS  PubMed  PubMed Central  Google Scholar 

  125. Alevizaki M, Saltiki K. Primary hyperparathyroidism in MEN2 syndromes. Recent Results Cancer Res. 2015;204:179–86.

    PubMed  Google Scholar 

  126. Vannucci L, Brandi ML. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Front Horm Res. 2019;51:52–62.

    CAS  PubMed  Google Scholar 

  127. Hannan FM, Nesbit MA, Zhang C, Cranston T, Curley AJ, Harding B, et al. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum Mol Genet. 2012;21:2768–78.

    CAS  PubMed  Google Scholar 

  128. Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, et al. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med. 2013;368:2476–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  129. Nesbit MA, Hannan FM, Howles SA, Reed AA, Cranston T, Thakker CE, et al. Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet. 2013;45:93–7.

    CAS  PubMed  Google Scholar 

  130. Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993;75:1297–303.

    CAS  PubMed  Google Scholar 

  131. Hendy GN, Cole DE. Genetic defects associated with familial and sporadic hyperparathyroidism. Front Horm Res. 2013;41:149–65.

    CAS  PubMed  Google Scholar 

  132. Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT. Hyperparathyroidism-jaw tumour syndrome. J Intern Med. 2003;253:634–42.

    CAS  PubMed  Google Scholar 

  133. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32:676–80.

    CAS  PubMed  Google Scholar 

  134. Chang M, French-Cornay D, Fan HY, Klein H, Denis CL, Jaehning JA. A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling. Mol Cell Biol. 1999;19:1056–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  135. Betz JL, Chang M, Washburn TM, Porter SE, Mueller CL, Jaehning JA. Phenotypic analysis of Paf1/RNA polymerase II complex mutations reveals connections to cell cycle regulation, protein synthesis, and lipid and nucleic acid metabolism. Mol Gen Genomics. 2002;268:272–85.

    CAS  Google Scholar 

  136. Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat. 2010;31:295–307.

    CAS  PubMed  Google Scholar 

  137. Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722–9.

    CAS  PubMed  Google Scholar 

  138. Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg. 2011;146:280–5.

    PubMed  Google Scholar 

  139. Gioviale MC, Damiano G, Altomare R, Maione C, Buscemi S, Buscemi G, Lo Monte AI. Intraoperative measurement of parathyroid hormone: a Copernican revolution in the surgical treatment of hyperparathyroidism. Int J Surg. 2016;28(Suppl 1):S99–102.

    PubMed  Google Scholar 

  140. Chen H, Pruhs Z, Starling JR, Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery. 2005;138:583–7.

    PubMed  Google Scholar 

  141. Barczynski M, Konturek A, Cichon S, Hubalewska-Dydejczyk A, Golkowski F, Huszno B. Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol. 2007;66:878–85.

    CAS  Google Scholar 

  142. Siperstein A, Berber E, Barbosa GF, Tsinberg M, Greene AB, Mitchell J, Milas M. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg. 2008;248:420–8.

    PubMed  Google Scholar 

  143. Zawawi F, Mlynarek AM, Cantor A, Varshney R, Black MJ, Hier MP, et al. Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it? J Otolaryngol Head Neck Surg. 2013;42:56.

    PubMed  PubMed Central  Google Scholar 

  144. Baloch ZW, LiVolsi VA. Intraoperative assessment of thyroid and parathyroid lesions. Semin Diagn Pathol. 2002;19:219–26.

    PubMed  Google Scholar 

  145. Anton RC, Wheeler TM. Frozen section of thyroid and parathyroid specimens. Arch Pathol Lab Med. 2005;129:1575–84.

    PubMed  Google Scholar 

  146. Westra WH, Pritchett DD, Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am J Surg Pathol. 1998;22:538–44.

    CAS  PubMed  Google Scholar 

  147. LiVolsi VA, Hamilton R. Intraoperative assessment of parathyroid gland pathology. A common view from the surgeon and the pathologist. Am J Clin Pathol. 1994;102:365–73.

    CAS  PubMed  Google Scholar 

  148. Black WC 3rd, Utley JR. The differential diagnosis of parathyroid adenoma and chief cell hyperplasia. Am J Clin Pathol. 1968;49:761–75.

    PubMed  Google Scholar 

  149. Saxe AW, Baier R, Tesluk H, Toreson W. The role of the pathologist in the surgical treatment of hyperparathyroidism. Surg Gynecol Obstet. 1985;161:101–5.

    CAS  PubMed  Google Scholar 

  150. Bornstein-Quevedo L, Gamboa-Domínguez A, Angeles-Angeles A, Reyes-Gutiérrez E, Vargas-Voráckova F, Gamino R, Herrera MF. Histologic diagnosis of primary hyperparathyroidism: a concordance analysis between three pathologists. Endocr Pathol. 2001;12:49–54.

    CAS  PubMed  Google Scholar 

  151. Bondeson AG, Bondeson L, Ljungberg O, Tibblin S. Fat staining in parathyroid disease--diagnostic value and impact on surgical strategy: clinicopathologic analysis of 191 cases. Hum Pathol. 1985;16:1255–63.

    CAS  PubMed  Google Scholar 

  152. Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151:959–68.

    PubMed  Google Scholar 

  153. Jason DS, Balentine CJ. Intraoperative decision making in parathyroid surgery. Surg Clin North Am. 2019;99:681–91.

    PubMed  Google Scholar 

  154. Horwitz CA, Myers WP, Foote FW Jr. Secondary malignant tumors of the parathyroid glands. Report of two cases with associated hypoparathyroidism. Am J Med. 1972;52:797–808.

    CAS  PubMed  Google Scholar 

  155. Shifrin A, LiVolsi V, Shifrin-Douglas S, Zheng M, Erler B, Matulewicz T, Davis J. Primary and metastatic parathyroid malignancies: a rare or underdiagnosed condition? J Clin Endocrinol Metab. 2015;100:E478–81.

    CAS  PubMed  Google Scholar 

  156. Bauer JL, Toluie S, Thompson LDR. Metastases to the parathyroid glands: a comprehensive literature review of 127 reported cases. Head Neck Pathol. 2018;12:534–41.

    PubMed  Google Scholar 

  157. Shifrin AL, LiVolsi VA, Zheng M, Lann DE, Fomin S, Naylor EC, et al. Neuroendocrine thymic carcinoma metastatic to the parathyroid gland that was reimplanted into the forearm in patient with multiple endocrine neoplasia type 1 syndrome: a challenging management dilemma. Endocr Pract. 2013;19:e163–7.

    PubMed  Google Scholar 

  158. Lee HE, Kim DH, Cho YH, Kim K, Chae SW, Sohn JH. Tumor-to-tumor metastasis: Hepatocellular carcinoma metastatic to parathyroid adenoma. Pathol Int. 2011;61:593–7.

    PubMed  Google Scholar 

  159. Lee SH, Kim BH, Bae MJ, Yi YS, Kim WJ, Jeon YK, et al. Concurrence of primary hyperparathyroidism and metastatic breast carcinoma affected a parathyroid gland. J Clin Endocrinol Metab. 2013;98:3127–30.

    CAS  PubMed  Google Scholar 

  160. Arduc A, Tutuncu YA, Dogan BA, Arikan Ileri AB, Tuna MM, Ozcan HN, et al. Parathyroid cysts. Am Surg. 2015;81:E163–5.

    PubMed  Google Scholar 

  161. Papavramidis TS, Chorti A, Pliakos I, Panidis S, Michalopoulos A. Parathyroid cysts: a review of 359 patients reported in the international literature. Medicine (Baltimore). 2018;97:e11399.

    Google Scholar 

  162. Aydoğdu K, Şahin F, İncekara F, Fındık G, Kaya S, Ağaçkıran Y. Diagnosis and management of parathyroid cysts: description with two cases. Turk Thorac J. 2015;16:201–3.

    PubMed  Google Scholar 

  163. Palmer JA, Brown WA, Kerr WH, Rosen IB, Watters NA. The surgical aspects of hyperparathyroidism. Arch Surg. 1975;110:1004–7.

    CAS  PubMed  Google Scholar 

  164. Reddick RL, Costa JC, Marx SJ. Parathyroid hyperplasia and parathyromatosis. Lancet. 1977;1(8010):549.

    CAS  PubMed  Google Scholar 

  165. Erickson LA. Parathyromatosis. In: Atlas of endocrine pathology. New York: Springer; 2014. p. 139–42.

    Google Scholar 

  166. Lee PC, Mateo RB, Clarke MR, Brown ML, Carty SE. Parathyromatosis: a cause for recurrent hyperparathyroidism. Endocr Pract. 2001;7:189–92.

    CAS  PubMed  Google Scholar 

  167. Hage MP, Salti I, El-Hajj FG. Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism. Metabolism. 2012;61:762–75.

    CAS  PubMed  Google Scholar 

  168. Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, et al. Presentation of hypoparathyroidism: Etiologies and clinical features. J Clin Endocrinol Metab. 2016;101:2300–12.

    CAS  PubMed  Google Scholar 

  169. Rao SD. Epidemiology of parathyroid disorders. Best Pract Res Clin Endocrinol Metab. 2018;32:773–80.

    PubMed  Google Scholar 

  170. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366–73.

    CAS  PubMed  Google Scholar 

  171. Brown EM. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism. Endocrinol Metab Clin N Am. 2009;38:437–45.

    CAS  Google Scholar 

  172. Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17:399–403.

    Google Scholar 

  173. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, et al. Positional cloning of the APECED gene. Nat Genet. 1997;17:393–8.

    CAS  PubMed  Google Scholar 

  174. Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES. AIRE-mutations and autoimmune disease. Curr Opin Immunol. 2016;43:8–15.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Jersey Shore University Medical Center, Neptune, NJ, USA

    Min Zheng

  2. Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA

    Virginia A. LiVolsi

Authors
  1. Min Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia A. LiVolsi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Min Zheng .

Editor information

Editors and Affiliations

  1. Department of Surgery, Jersey Shore University Medical Center, Neptune, NJ, USA

    Alexander L. Shifrin

  2. Lenox Hill Radiology, New York, NY, USA

    L. Daniel Neistadt

  3. Department of Radiology, Jersey Shore University Medical Center, Neptune, NJ, USA

    Pritinder K. Thind

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zheng, M., LiVolsi, V.A. (2020). Pathology of the Parathyroid Glands. In: Shifrin, A.L., Neistadt, L.D., Thind, P.K. (eds) Atlas of Parathyroid Imaging and Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-40959-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-40959-3_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-40958-6

  • Online ISBN: 978-3-030-40959-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation